4
Changes in Ownership
Krystal Biotech, Inc. Filed Acc 0001209059-26-000003
Director sold 18,950 shares at an average $261.41 ($4,953,694)
- Director acquired 18,950 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROSSI DINO A · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-19 | Exercise or conversion : show line 1 in the form | +18,950 | $8.79 | $166,571 | 97,641 | D |
| 2026-02-19 | Sale : show line 2 in the form | −8,116 | $260.49 | $2,114,103 | 89,525 | D |
| 2026-02-19 | Sale : show line 3 in the form | −10,834 | $262.10 | $2,839,591 | 78,691 | D |
| Open-market sales · 18,950 sh · avg $261.41 · $4,953,694 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-19 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −18,950 | 0 | D |
Loading xslF345X05/wk-form4_1771892075.xml…